Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d47ace037a583cc99c3f4382a8d5f564 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0453 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2013-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc5bfe5c10a6232172dad3b1cb79b3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7dd80959d5c57bf75bb4fa8cfba9d2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c568269a94d5cdcb0567eb2814565fb7 |
publicationDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2898246-A1 |
titleOfInvention |
Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma |
abstract |
A radiopharmaceutical composition is disclosed comprising novel iodometomidate derivatives of formula (I) which bind specifically to adrenal enzymes and which exhibit an improved stability. The compounds of formula (I) are suitable for use in a diagnostic imaging method, e.g. for diagnosis of adrenocortical carcinoma. The compounds of formula (I) are further suitable for use in the treatment of adrenocortical carcinoma, by means of radionuclide therapy. |
priorityDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |